{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:50:59Z","timestamp":1740138659469,"version":"3.37.3"},"reference-count":110,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100011722","name":"funding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14656566.2021.2016697","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T10:30:18Z","timestamp":1639564218000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Advances with pharmacotherapy for the treatment of interstitial lung disease"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-895X","authenticated-orcid":false,"given":"Alessia","family":"Comes","sequence":"first","affiliation":[{"name":"Dipartimento Di Scienze Mediche E Chirurgiche, Unit\u00e0 Operativa Complessa Di Pneumologia, Fondazione Policlinico Universitario Agostino Gemelli, Irccs, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-9388","authenticated-orcid":false,"given":"Giacomo","family":"Sgalla","sequence":"additional","affiliation":[{"name":"Dipartimento Di Scienze Mediche E Chirurgiche, Unit\u00e0 Operativa Complessa Di Pneumologia, Fondazione Policlinico Universitario Agostino Gemelli, Irccs, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Perrotta","sequence":"additional","affiliation":[{"name":"Dipartimento Di Scienze Mediche E Chirurgiche, Unit\u00e0 Operativa Complessa Di Pneumologia, Fondazione Policlinico Universitario Agostino Gemelli, Irccs, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Richeldi","sequence":"additional","affiliation":[{"name":"Dipartimento Di Scienze Mediche E Chirurgiche, Unit\u00e0 Operativa Complessa Di Pneumologia, Fondazione Policlinico Universitario Agostino Gemelli, Irccs, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2005230"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30866-8"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.04.016"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-016-9912-1"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105803"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.02.014"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-571OC"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00005209"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174914"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103690"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.02.001"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30339-4"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201706-1301OC"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0488OC"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811737"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1030-4"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.581828"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.06.049"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.11.007"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202403"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22960"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4956"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01839-0"},{"issue":"1","key":"e_1_3_4_30_1","first-page":"1","article-title":"Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls","volume":"21","author":"Krempaska K","year":"2020","unstructured":"Krempaska K, Barnowski S, Gavini J, et al. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respir Res. 2020;21(1):1\u201316.","journal-title":"Respir Res"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00628-2018"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0082-2017"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-017-0437-z"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202103-266OC"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.O-06-449"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.resp.2020.103546","article-title":"Galactin-1, 3 and 9: potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases","volume":"282","author":"d\u2019Alessandro M","year":"2020","unstructured":"d\u2019Alessandro M, De Vita E, Bergantini L, et al. Galactin-1, 3 and 9: potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases. Respir Physiol Neurobiol. 2020;282:7\u201310.","journal-title":"Respir Physiol Neurobiol"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02559-2020"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0509PP"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301761"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.4.614"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02442-2019"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0004OC"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-5"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30181-4"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000422"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-5-S1-S24"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01030-2015"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30262-0"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.10.5537"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2013.01.008"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30172-9"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.6129"},{"key":"e_1_3_4_53_1","first-page":"103","article-title":"Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia","volume":"30","author":"Song JW","year":"2013","unstructured":"Song JW, Lee H-K, Lee CK, et al. Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis, Vasc Diffus Lung Dis off J WASOG. 2013;30:103\u2013112.","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis off J WASOG"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2021"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13365"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.04.007"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.03.004"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.05.004"},{"key":"e_1_3_4_59_1","first-page":"S161","article-title":"Intravenous versus oral cyclophosphamide for lung and\/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials","volume":"38","author":"Bruni C","year":"2020","unstructured":"Bruni C, Tashkin DP, Steen V, et al. Intravenous versus oral cyclophosphamide for lung and\/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials. Clin Exp Rheumatol. 2020;38:S161\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200477"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010908.pub2"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30152-7"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04846-1"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305LU2109OA"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00232-5"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05794-5"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124205"},{"key":"e_1_3_4_71_1","first-page":"170","article-title":"Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian scleroderma cohort study","volume":"34","author":"Owen C","year":"2016","unstructured":"Owen C, Ngian G-S, Elford K, et al. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian scleroderma cohort study. Clin Exp Rheumatol. 2016;34 Suppl 1:170\u2013176.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-013-9499-8"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1517-z"},{"issue":"6","key":"e_1_3_4_74_1","first-page":"1064","article-title":"Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study","volume":"35","author":"B\u00e9rezn\u00e9 A","year":"2008","unstructured":"B\u00e9rezn\u00e9 A, Ranque B, Valeyre D, et al. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. J Rheumatol. 2008;35(6):1064\u20131072.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.11.007"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41451"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38322"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250339"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00337-2020"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020154"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60982-3"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211682"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30318-0"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12214"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04557-7"},{"key":"e_1_3_4_86_1","first-page":"100770","article-title":"Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): a double-blind placebo-controlled randomize","volume":"78","author":"Bejan-Angoulvant T","year":"2020","unstructured":"Bejan-Angoulvant T, Naccache JM, Caille A, et al. Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): a double-blind placebo-controlled randomize. Respir Med Res. 2020;78:100770.","journal-title":"Respir Med Res"},{"key":"e_1_3_4_87_1","first-page":"1882","article-title":"Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study","volume":"60","author":"Kelly CA","year":"2021","unstructured":"Kelly CA, Nisar M, Arthanari S, et al. Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study. Revmatol. 2021;60:1882\u20131890.","journal-title":"Revmatol"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102830"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-12-200606200-00003"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05854-w"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key287"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008250"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6652845"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151322"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41576"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30330-1"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.029"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00016-2017"},{"key":"e_1_3_4_99_1","first-page":"139","article-title":"Pirfenidone in chronic hypersensitivity pneumonitis: a real-life experience","volume":"35","author":"Shibata S","year":"2018","unstructured":"Shibata S, Furusawa H, Inase N., et al. Pirfenidone in chronic hypersensitivity pneumonitis: a real-life experience. Sarcoidosis, Vasc Diffus Lung Dis off J WASOG. 2018;35:139\u2013142.","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis off J WASOG"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2019.08.019"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00152-2020"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00692-2018"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30554-3"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30341-8"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1908681"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30036-9"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001114.pub2"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.10.008"},{"key":"e_1_3_4_110_1","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss NJ","year":"2014","unstructured":"Sweiss NJ, Noth I, Mirsaeidi M, et al. Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis. Sarcoidosis, Vasc Diffus Lung Dis off J WASOG. 2014;31:46\u201354.","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis off J WASOG"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30554-3"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.2016697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:41:43Z","timestamp":1732092103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.2016697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14656566.2021.2016697"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.2016697","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"type":"print","value":"1465-6566"},{"type":"electronic","value":"1744-7666"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}